Onco-Nutrition and Supplements Market Outlook - 2027
The nutritional status of patient suffering with cancer is affected negatively due to cancer itself or indirectly via tumor-induced metabolic changes also referred to as cancer cachexia or cancer-induced malnutrition. Most of the oncology treatments cause side effects that reduce appetite and food intake. Some of these adverse effects persist for long-term. Hence, proper nutrition during oncology therapeutics is crucial. Appropriate nutrition is clinical for maintaining proper health during and post cancer treatment. Research and studies have also found evidences regarding the proper nutrition that helps in boosting the immunity and aids in prevention of cancer and simultaneously increases the effectiveness of cancer therapeutics. Oncology patients understand the importance of essential nutrition as it has enormous effect on the treatment. Consuming a variety of foods containing nutritional elements and well-balanced meals assist them in staying stronger during the course of treatment. It also aids in maintaining proper body weight, preserving optimal levels of energy and strength, reduces the risk and complications related to infection and helps in rapid recovery. High protein diets are recommended for patients suffering from cancer.
COVID – 19 scenario analysis:
- Due to the COVID – 19 outbreak, majority of healthcare, pharmaceutical and biotechnology organizations have concentrated on diagnostics kits, safety wearables (PPE kits, face shields, masks) and treatment therapies and medication against Novel coronavirus
- R&D labs are also focusing on finding a breakthrough vaccine against Novel coronavirus
- In addition, the medical professionals are engaged in providing COVID-19 related services, as a result, other healthcare segments have to face negligence
- As there is strain on healthcare providers and the hospitals are flooding with patients suffering with SARS-CoV-2 and the intake capacity of hospitals already at its peak
- Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to oncology nutrition has been reduced and this segment have to face negligence subsequently causing negative impact on onco-nutrition and supplements market
- Some research from China, has also stated that cancer patients are at higher risk as they’re vulnerable against SARS-CoV-2 and have higher chances of getting infected with the virus
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
The onco-nutrition and supplements market is expected to witness significant growth in coming years due to factors such as increasing prevalence of cancer creating large patient pools, shifting focus to enteral from parenteral nutrition, rising demand for appropriate nutritional intake in cancer patients, rising incidences of patients suffering with malnutrition due to cancer itself as well as cancer therapies, and increasing clinical research in the field of nutritional interventions in disease management. The other factors like the increasing demand for nutritional products, availability of nutritional consumables and rising need to meet oncology patient’s daily nutritional intake. Furthermore, the rising requirement related to enteral nutrition for patients suffering with head and neck cancer would facilitate the market growth. Increasing number of cancer patients surge the uptake of tube feeding formulas, which helps in proper nutritional intake in extreme medical conditions due to cancer. Hence, the rise in the enteral nutrition will stimulate the growth of onco-nutrition and supplements market.
On the contrary, the unfavorable reimbursement policies related with the tube feeding systems and negligence of importance of nutrition in cancer therapeutics and recovery are some factors anticipated to impede the growth of the onco-nutrition and supplements market to a certain extent.
Having said that, drastic rise in demand for meeting nutritional intake in the homecare settings coupled with high usage of nutritional supplements will amplify the market growth and create growth and market expansion opportunities for the onco-nutrition and supplements market. Statistics further suggest that approximately 1.5 million people in the U.S. are diagnosed with some form of cancer every year which facilitates the higher consumption of nutritional supplements including herbs, vitamins, and extracts that aid in strengthening the immunity and provide relief from adverse effects of radiation and chemotherapy.
Dietary factors and changing lifestyle to propel the market
Dietary factors play a pivotal role in the acquiring and treatment of cancer. Unhealthy diet coupled with unhealthy lifestyle increase chances of getting affected with cancer. Obesity and diet can be directly associated with almost 30% to 35% of fatalities caused due to cancer, while lethargic lifestyle and physical inactivity results in 7% cancer risk. Almost 85% of all cancer cases around the world are linked with changing diet and lifestyle. Food and nutritional intake significantly contributes to cancer development on one hand and cancer prevention and effective management on the other. Clinical research outcomes are constantly being upgraded by using Oncology Nutrition in integration with therapeutics as a holistic approach to oncology. Thus the change in dietary factors coupled with lethargic lifestyle would fuel the market growth. Also, the World Health Organization (WHO) in their report, mentioned the rate of obesity has tripled since 1975 worldwide. Year 2016 saw over 1.9 billion adults belonging to age group 18 years or above were overweight and out of them, over one third of people were obese. As a result, problems arising due to obesity would create demand for onco-nutrition and supplements thereby propelling the market growth.
Rising prevalence of cancer to boost the growth
According to the Cancer Research UK, around 17 million cancer cases were registered in 2018, out of which 56% of the cases were fatal. There are many key factors that may affect the success rate of chemo and radiation therapy and a person's survival rate such as age, overall health and cancer stage. As per a research report by the World Health Organization (WHO), in low- and middle-income countries, around 70% of deaths occurs due to cancer. Increase in smoking habits, genetic mutation, alcohol and hormones consumption, urban air pollution are the frequent reasons for the increasing number of cancer patients in the world. Rising number of cancer across the globe is proving to be significant for boosting the growth of onco-nutrition and supplements market.
Key benefits of the report:
- This study presents the analytical depiction of the global onco-nutrition and supplements industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global onco-nutrition and supplements market share.
- The current market is quantitatively analyzed to highlight the global onco-nutrition and supplements market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global onco-nutrition and supplements market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Onco-nutrition and supplements Market research report:
- What are the leading market players active in the onco-nutrition and supplements market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Onco-Nutrition and Supplements Market Report Highlights
| Aspects | Details |
 By Cancer Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | Meiji Holdings., Fresenius Kabi AG, B. Braun Melsungen AG, Mead Johnson Nutrition Company, Nestle S.A, Global Health Products, Danone, Abbott Laboratories, Hormel Foods, Victus |
 Other Players | Pfizer Inc., Grifols S.A., Baxter International, Inc |
Loading Table Of Content...
